India's Rossari Biotech slides on Q3 profit fall
22/01/2025 05:12
** Rossari Biotech ROSB.NS falls as much as 5.8% to 755.7
rupees; last down 4.1%
** Specialty chemicals maker's Q3 consol net profit drops
7.8% y/y
** Stock moved below its 100-day and 200-day simple moving
avgs after result
** More than 82,000 shares traded, 1.4x its 30-day avg
** Stock rated "strong buy" on avg; median PT is 1,004
rupees, ~30.4% higher than current price - LSEG
** ROSB fell 2.8% in 2024
(Reporting by Anuran Sadhu in Bengaluru)
((Anuran.Sadhu@thomsonreuters.com; +91 8697274436;))
Recent news on Rossari Biotech
See all newsIndia's Rossari Biotech falls after ICICI Securities lowers PT
India's Rossari Biotech slips after Q1 net profit falls sequentially
Brief: Rossari Biotech Unit Commissions 15,000 MTPA Ethoxylation Capacity At Dahej
Brief: Rossari Biotech To Incorporate Subsidiary In Singapore With $10 Million Investment
India's Rossari Biotech gains on Q2 profit rise